Form D · Other

Pasteuria Bioscience, Inc.

Alachua, FL · CIK 0001400050

Offering snapshot reported Sep 8, 2010 · SEC filing

Reported sold
$1.88M
Offering amount: $3.75M
Investors reported
3
Form D · investor count
Minimum accepted
$500K
Reported outside-investor minimum
First sale
Aug 24, 2010
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 8, 2010Initial$1,875,000No comparison3SEC filing
Jul 16, 2009Initial$1,365,000No comparison3SEC filing
Jun 6, 2008PaperNot reportedNo comparisonNot reportedSEC filing
May 7, 2007PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Debt, Option to acquire, Security to be acquired
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-147402

Source: Form D, filed Sep 8, 2010. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Fouad Azaam, Ph.D. Director
Timothy Cockshutt Director
David N. Duncan, Ph.D. Director, Executive
Al Kern Director
Martijn Kleijwegt Director
Richard Molloy Director
Jorg Riesmeier Director
Kelly Smith Executive

Issuer details

Industry: Other (See others in industry)

Address:
12085 Research Drive
Alachua, FL, 32615